(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities in cell sorting include rising demand for cell-based therapies, driven by their role in personalized medicine and regenerative treatments. Technological innovations enhance precision and scalability, catering to pharma and clinical needs. Growth is bolstered by advancements in microfluidics, AI, and global market expansion.Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "Cell Sorting - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Cell Sorting was estimated at US$948.7 Million in 2024 and is projected to reach US$1.6 Billion by 2030, growing at a CAGR of 9.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
How Is Cell Sorting Revolutionizing Biomedical Research and Clinical Applications?
Cell sorting is a critical technique in both biomedical research and clinical applications, allowing scientists and clinicians to separate specific cell populations from heterogeneous mixtures based on their unique characteristics. This process is essential for advancing our understanding of cellular biology, disease mechanisms, and therapeutic development. Cell sorting technologies, such as Fluorescence-Activated Cell Sorting (FACS) and Magnetic-Activated Cell Sorting (MACS), have made it possible to isolate cells based on size, morphology, protein expression, or fluorescent markers, enabling precise analysis of specific cell types.
In research, cell sorting plays a crucial role in fields like immunology, oncology, and stem cell biology. For instance, it allows scientists to isolate immune cells to study their behavior in response to infection or therapy, or to sort cancer cells for genetic profiling to better understand tumor progression and drug resistance. In clinical applications, cell sorting is indispensable in procedures like bone marrow transplants and in the manufacturing of cell-based therapies, where pure populations of therapeutic cells must be isolated to ensure effectiveness and safety. As cell sorting technologies advance, they continue to drive breakthroughs in both basic science and therapeutic innovation.
Why Is Cell Sorting Essential for the Development of Cell-Based Therapies?
Cell sorting is integral to the development of cell-based therapies, particularly in areas such as immunotherapy and regenerative medicine. In therapies like CAR-T cell treatment, immune cells are extracted from a patient's blood, genetically modified to target cancer cells, expanded, and then reinfused into the patient. The success of this therapy depends on the precise sorting and isolation of T cells, ensuring that only the cells capable of targeting tumors are used. Similarly, in stem cell therapies, sorting technologies are used to purify stem cell populations from tissues such as bone marrow, which can then be used to regenerate damaged tissues or treat degenerative diseases.
Ensuring high-purity, viable cell populations through advanced sorting techniques is critical for the safety and efficacy of these therapies, as contamination with unwanted cell types can lead to adverse reactions or ineffective treatment. Beyond their role in treatment development, cell sorting technologies are also used to monitor patient responses to therapies by isolating specific immune or tumor cells for analysis. This capability is key for optimizing treatment plans and improving therapeutic outcomes, making cell sorting an essential tool in the advancement of personalized medicine.
What Are the Key Growth Drivers in the Cell Sorting Market?
The growth in the cell sorting market is driven by several factors, including the rising demand for cell-based therapies, advancements in biotechnology, and the increasing need for high-precision cell analysis in both research and clinical settings. One of the primary drivers is the expanding use of cell sorting in immunotherapy, particularly in the development of CAR-T cell therapies, which require the isolation of specific immune cells for genetic modification and therapeutic use.
As more cell-based therapies enter clinical practice, the need for reliable and scalable cell sorting technologies continues to grow. Technological innovations, such as automated and microfluidic-based sorting systems, are further propelling market growth by making cell sorting more accessible and efficient for laboratories of all sizes. Additionally, the increasing focus on personalized medicine is fueling demand for cell sorting, as it allows for the isolation and analysis of patient-specific cells, enabling the development of targeted treatments based on individual cellular profiles. The rise of single-cell analysis, which requires the sorting and isolation of individual cells for detailed molecular studies, is also contributing to the growth of the cell sorting market.
Furthermore, the growing prevalence of chronic diseases, such as cancer and autoimmune disorders, is driving demand for advanced cell sorting technologies that can support the development of new diagnostics and treatments. With continued investment in life sciences research and the advancement of sorting technologies, the cell sorting market is expected to experience robust growth in the coming years.
SCOPE OF STUDY:
The report analyzes the Cell Sorting market in terms of units by the following segments:
Component (Cell Sorters, Reagents & Consumables, Services) Technology (Fluorescence-Based Droplet Cell Sorting, Magnetic-Activated Cell Sorting, MEMS-Microfluidics) End-Use (Research Institutions, Medical Schools & Academic Institutions, Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories)
Key Insights:
Market Growth : Understand the significant growth trajectory of the Cell Sorters segment, which is expected to reach US$862.0 Million by 2030 with a CAGR of a 9.9%. The Reagents & Consumables segment is also set to grow at 9.1% CAGR over the analysis period. Regional Analysis : Gain insights into the U.S. market, valued at $267.4 Million in 2024, and China, forecasted to grow at an impressive 8.5% CAGR to reach $243.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
Comprehensive Market Data : Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030. In-Depth Regional Analysis : Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Company Profiles : Coverage of players such as Affymetrix, Beckman Coulter, Becton, Dickinson and Company, Bio-Rad Laboratories, Sysmex Partec, and more. Complimentary Updates : Receive free report updates for one year to keep you informed of the latest market developments.
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis.
Key updates include:
Tariff and Trade Impact: I nsights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs. Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015. Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends. Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape. Competitive Intelligence : Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players. Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
Key Attributes:
CONTACT:
CONTACT:
Laura Wood,Senior Press Manager
...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment